 | • レポートコード：MRC20A33 • 出版社/出版日：Transparency Market Research / 2020年10月29日 • レポート形態：英文、PDF、226ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、網膜疾患治療の世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、市場展望、疾患別（加齢黄斑変性、糖尿病網膜症、糖尿病黄斑浮腫、その他）分析、薬効分類別分析、剤形別分析、流通チャンネル別分析、地域別（米国、ヨーロッパ、中国、ロシア、その他）分析、競争状況などを掲載しています。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・市場展望 ・網膜疾患治療の世界市場規模：疾患別（加齢黄斑変性、糖尿病網膜症、糖尿病黄斑浮腫、その他） ・網膜疾患治療の世界市場規模：薬効分類別 ・網膜疾患治療の世界市場規模：剤形別 ・網膜疾患治療の世界市場規模：流通チャンネル別 ・網膜疾患治療の世界市場規模：地域別（米国、ヨーロッパ、中国、ロシア、その他） ・競争状況 |
Retinal Disorders Treatment Market – Scope of the Report
TMR’s report on the global retinal disorders treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global retinal disorders treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global retinal disorders treatment market from 2020 to 2030.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global retinal disorders treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global retinal disorders treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global retinal disorders treatment market. These serve as valuable tools for existing market players as well as entities interested in participating in the global retinal disorders treatment market.
The report also delves into the competition landscape of the global retinal disorders treatment market. Key players operating in the global retinal disorders treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global retinal disorders treatment market that have been profiled in this report.
Key Questions Answered in Retinal Disorders Treatment Report
What is the sales/revenue generated by retinal disorders treatment providers across all regions during the forecast period?
What are the opportunities in the global retinal disorders treatment market?
What are the major drivers, restraints, opportunities, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Retinal Disorders Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global retinal disorders treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global retinal disorders treatment market in terms of indication, dosage form, therapeutic class, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global retinal disorders treatment market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Retinal Disorders Treatment Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Retinal Disorders Treatment Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. COVID-19 Pandemics Impact on Industry
5.2. Clinical Trial Analysis
5.3. Regulatory Scenario
5.4. Pipeline Analysis
5.5. Key Potential Customers
5.6. Key Vendor and Distributor Analysis
5.7. Key Industry Events
5.8. Reimbursement Scenario
5.9. Retinal Disorders: Epidemiology Forecast
6. Global Retinal Disorders Treatment Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
6.2.1. Macular Degeneration
6.2.1.1. Dry Macular Degeneration
6.2.1.2. Wet Macular Degeneration
6.2.2. Diabetic Retinopathy
6.2.3. Diabetic Macular Edema
6.2.4. Others
6.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Indication
7. Global Retinal Disorders Treatment Market Analysis and Forecast, by Therapeutic Class
7.1. Introduction & Definition
7.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
7.2.1. Anti-VEGF Agents
7.2.2. Others
7.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class
8. Global Retinal Disorders Treatment Market Analysis and Forecast, by Dosage Form
8.1. Introduction & Definition
8.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
8.2.1. Gels
8.2.2. Eye Solutions
8.2.3. Capsules & Tablets
8.2.4. Eye Drops
8.2.5. Ointments
8.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form
9. Global Retinal Disorders Treatment Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Sales
9.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel
10. Global Retinal Disorders Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Region
10.2.1. U.S.
10.2.2. Europe
10.2.3. China
10.2.4. Russia
10.2.5. Rest of the World (RoW)
10.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Region
11. U.S. Retinal Disorders Treatment Market Analysis and Forecast
11.1. Introduction
11.2. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
11.2.1. Macular Degeneration
11.2.1.1. Dry Macular Degeneration
11.2.1.2. Wet Macular Degeneration
11.2.2. Diabetic Retinopathy
11.2.3. Diabetic Macular Edema
11.2.4. Others
11.3. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
11.3.1. Anti-VEGF Agents
11.3.2. Others
11.4. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
11.4.1. Gels
11.4.2. Eye Solutions
11.4.3. Capsules & Tablets
11.4.4. Eye Drops
11.4.5. Ointments
11.5. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Sales
11.6. U.S. Retinal Disorders Treatment Market Attractiveness Analysis
11.6.1. By Indication
11.6.2. By Therapeutic Class
11.6.3. By Dosage Form
11.6.4. By Distribution Channel
12. Europe Retinal Disorders Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
12.2.1. Macular Degeneration
12.2.1.1. Dry Macular Degeneration
12.2.1.2. Wet Macular Degeneration
12.2.2. Diabetic Retinopathy
12.2.3. Diabetic Macular Edema
12.2.4. Others
12.3. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
12.3.1. Anti-VEGF Agents
12.3.2. Others
12.4. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
12.4.1. Gels
12.4.2. Eye Solutions
12.4.3. Capsules & Tablets
12.4.4. Eye Drops
12.4.5. Ointments
12.5. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Sales
12.6. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Retinal Disorders Treatment Market Attractiveness Analysis
12.7.1. By Indication
12.7.2. By Therapeutic Class
12.7.3. By Dosage Form
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. China Retinal Disorders Treatment Market Analysis and Forecast
13.1. Introduction
13.2. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
13.2.1. Macular Degeneration
13.2.1.1. Dry Macular Degeneration
13.2.1.2. Wet Macular Degeneration
13.2.2. Diabetic Retinopathy
13.2.3. Diabetic Macular Edema
13.2.4. Others
13.3. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
13.3.1. Anti-VEGF Agents
13.3.2. Others
13.4. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
13.4.1. Gels
13.4.2. Eye Solutions
13.4.3. Capsules & Tablets
13.4.4. Eye Drops
13.4.5. Ointments
13.5. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Sales
13.6. China Retinal Disorders Treatment Market Attractiveness Analysis
13.6.1. By Indication
13.6.2. By Therapeutic Class
13.6.3. By Dosage Form
13.6.4. By Distribution Channel
14. Russia Retinal Disorders Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
14.2.1. Macular Degeneration
14.2.1.1. Dry Macular Degeneration
14.2.1.2. Wet Macular Degeneration
14.2.2. Diabetic Retinopathy
14.2.3. Diabetic Macular Edema
14.2.4. Others
14.3. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
14.3.1. Anti-VEGF Agents
14.3.2. Others
14.4. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
14.4.1. Gels
14.4.2. Eye Solutions
14.4.3. Capsules & Tablets
14.4.4. Eye Drops
14.4.5. Ointments
14.5. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Sales
14.6. Russia Retinal Disorders Treatment Market Attractiveness Analysis
14.6.1. By Indication
14.6.2. By Therapeutic Class
14.6.3. By Dosage Form
14.6.4. By Distribution Channel
15. Rest of the World Retinal Disorders Treatment Market Analysis and Forecast
15.1. Introduction
15.2. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
15.2.1. Macular Degeneration
15.2.1.1. Dry Macular Degeneration
15.2.1.2. Wet Macular Degeneration
15.2.2. Diabetic Retinopathy
15.2.3. Diabetic Macular Edema
15.2.4. Others
15.3. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
15.3.1. Anti-VEGF Agents
15.3.2. Others
15.4. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
15.4.1. Gels
15.4.2. Eye Solutions
15.4.3. Capsules & Tablets
15.4.4. Eye Drops
15.4.5. Ointments
15.5. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Sales
15.6. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
15.6.1. Canada
15.6.2. India
15.6.3. Japan
15.6.4. Australia
15.6.5. Brazil
15.6.6. Rest of Rest of the World
15.7. Rest of the World Retinal Disorders Treatment Market Attractiveness Analysis
15.7.1. By Indication
15.7.2. By Therapeutic Class
15.7.3. By Dosage Form
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Position Analysis, by Company, 2019
16.2. Company Profiles
16.2.1. Allergan plc
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Growth Strategies
16.2.1.3. SWOT Analysis
16.2.2. Bayer AG
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Growth Strategies
16.2.2.3. SWOT Analysis
16.2.3. F. Hoffmann-La Roche Ltd.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Growth Strategies
16.2.3.3. SWOT Analysis
16.2.4. Graybug Vision, Inc.
16.2.4.1. Company Overview (HQ, Business Segments)
16.2.4.2. Growth Strategies
16.2.4.3. SWOT Analysis
16.2.5. Kubota Pharmaceutical Holdings Co., Ltd.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Growth Strategies
16.2.5.3. SWOT Analysis
16.2.6. Novartis AG
16.2.6.1. Company Overview (HQ, Business Segments)
16.2.6.2. Growth Strategies
16.2.6.3. SWOT Analysis
16.2.7. Pfizer, Inc.
16.2.7.1. Company Overview (HQ, Business Segments)
16.2.7.2. Growth Strategies
16.2.7.3. SWOT Analysis
16.2.8. Regeneron Pharmaceuticals, Inc.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Growth Strategies
16.2.8.3. SWOT Analysis
16.2.9. Santen Pharmaceutical Co., Ltd.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Growth Strategies
16.2.9.3. SWOT Analysis
16.2.10. Takeda Pharmaceutical Company Limited
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Growth Strategies
16.2.10.3. SWOT Analysis
List of TablesTable 01: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 02: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 03: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 04: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 05: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 06: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 07: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 08: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 09: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 10: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 11: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 12: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 13: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 14: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 15: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 16: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 17: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 18: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 19: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 20: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 21: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 22: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 23: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 24: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018–2030
Table 25: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 26: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 27: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030